Notifications
Back
Notification settings
Back
More
Post notifications
Post reactions
Be notified when someone leaves a comment or a reply to your post or comment.
Updates and news
Stay ahead of important updates and news from the site.
Alarm
My account
Sign out
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Close
JNPMEDI - Life Science RDC Company
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Contact Us
Request for Quotation
JNPMEDI - Life Science RDC Company
Home
About Us
About JNPMEDI
Team
History
Software
Professional Services
Professional Services
AWS MSP Service
Media
Careers
Contact Us
Request for Quotation
EN
KR
EN
MENU
JNPMEDI - Life Science RDC Company
EN
KR
EN
Media
Stay up to date with the latest news from JNPMEDI
All
[News]
[Story]
[People]
Media
Stay up to date with the latest news from JNPMEDI
All
[News]
[Story]
[People]
Media
223
Search
Updates and news
[News]
JNPMEDI Successfully Concludes Pharma & Biotech Out-Licensing Strategy Pitch Competition with KNAPS
| Final round held at Maven Hall on the 31st, highlighting insights into out-licensing strategies |
0
0
JNPMEDI PR
5 Aug 2025
Views
167
Updates and news
[Story]
[JNPMEDI Column] Patient-Centered Digital Healthcare & Clinical Trials: Turning Innovation into Reality
From left: Hoyoung Khang, PL and Soyeon Kwon, Consultant at JNPMEDI (Photo courtesy of JNPMEDI)
0
0
JNPMEDI PR
28 Jul 2025
Views
532
Updates and news
[News]
Biopharma Companies Make Strategic Moves with ‘Dedicated Teams’ Amidst Regulatory Shifts... Solidifying Competitive Edge with Specialized Expertise
| Transforming ‘Regulation’—a structural hurdle in the biopharma industry—in
0
0
JNPMEDI PR
10 Jul 2025
Views
257
Updates and news
[Story]
[JNPMEDI Column] In Digital Healthcare, Technology Alone Isn’t Enough — New Global Standards Set by FDA and CE MDR
▲From left, HyeJeoung Lee, Director at JNPMEDI, and HanYeong Oh, PL at JNPMEDI (Photo courtesy of J
0
0
JNPMEDI PR
10 Jul 2025
Views
447
Updates and news
[Story]
June 2025, Medical Device Clinical Trial Plan Approval Status
Hello, JNPMEDI has prepared medical device clinical trial plans approved in June 2025. Shall we ta
0
0
JNPMEDI PR
9 Jul 2025
Views
300
Updates and news
[Story]
[Travelogue] JNPMEDI at K-BioX Summit and BIO USA 2025
Boston in June was buzzing with the vibrant energy of the biotech industry. JNPMEDI attended both
0
0
JNPMEDI PR
9 Jul 2025
Views
292
Updates and news
[News]
JNPMEDI: “Cutting Clinical Trial Costs and Timelines with AI Solutions”
JNPMEDI, an AI platform-based clinical trial consulting firm, announced on the 6th that it is enha
0
0
JNPMEDI PR
7 Jul 2025
Views
308
Updates and news
[Story]
[JNPMEDI Column] Between Regulation and Innovation — Survival Strategies for Digital Healthcare Startups Under the “Digital Medical Products Act”
✍️ SeungMi Lee, Partner at JNPMEDI The Choice of a Coffee, and the Choice of Digital Healthcare
0
0
JNPMEDI PR
30 Jun 2025
Views
282
Updates and news
[News]
JNPMEDI Partners with MCRA and IQVIA — Accelerating U.S. Market Entry for Korean Medical Device Companies
| From FDA approval to reimbursement and clinical strategy… First practical joint workshop he
0
0
JNPMEDI PR
26 Jun 2025
Views
332
Previous
1
2
3
4
5
6
7
8
9
Next
